NewAmsterdam Pharma Company N.V.NAMSNASDAQ
Loading
Cash Flow PerformanceElevated
Percentile Rank80
Studio
Year-over-Year Change

Free cash flow yield

Percentile
P80
Within normal range
vs 3Y Ago
-0.7x
Contraction
Streak
2 yr
Consecutive growthElevated
PeriodValueYoY Change
2025-3.69%+43.8%
2024-6.57%+57.3%
2023-15.39%-404.6%
20225.05%+129.6%
2021-17.07%-336.9%
2020-3.91%-